To support the strategic goals of the Inflammation & Immunology (I&I) Business Unit (BU) to ensure optimal reimbursement and access of Eucrisa, a new treatment for atopic dermatitis that is launching globally. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of our product. Overall, the I&I therapy area is committed to medical dermatology, rheumatology, and gastroenterology. This role will serve as the Global HEOR lead to support the launch of Eucrisa worldwide.
The HEOR Director will function with a One PHI mindset and will work in a closely aligned fashion with leadership and PHI colleagues to ensure there is a single and coordinated view on strategy and delivery for PHI to the I&I business. The HEOR Director will partner with Global Product Development, Commercial Development, Global Medical, and other cross-functional teams to develop and implement health outcomes research strategies to support Eucrisa globally. Within PHI, the HEOR director will collaborate with the Centers of Excellence such as PCOA and RWDnA.
- Lead the development of HEOR strategy to support the value of Eucrisa in close partnership with other PHI colleagues
- Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements. Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
- Development and validation of new Patient Reported Outcomes measures as appropriate for inclusion across clinical trials, registries, and prospective real world studies.
- Lead the execution of HEOR studies and projects (including Non-Interventional Studies, registries, etc.) in alignment with the global HEOR strategy and demonstrate the value proposition for Eucrisa.
- Identify opportunities to partner with I&I BU external customers to conduct HEOR projects in support of asset strategies
- Lead the timely development of deliverables including global value dossiers (GVDs), evidence blueprints, economic models, and innovative tools to successfully support global launch, reimbursement and access requirements in conjunction with the regions/countries.
- Lead the coordination of input from local country/regional HEOR teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrated evidence strategy to support global market access needs at time of launch.
- Develop real world evidence generation strategies and flawlessly execute studies (e.g., burden of illness studies, epidemiology studies, etc).
- Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community settings to support asset strategies.
- Collaborate with local health and value affiliates and enable local model adaptations and updates throughout the product life cycle.
- Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer products.
- Lead the development of appropriate data dissemination plans and communicate evidence generated via publications and conference presentations.
- Minimum Masters degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics.
- Minimum 8 years' experience in health outcomes and related fields, 5 of which are as part of global health economics and/or outcomes research teams in a pharmaceutical company.
- Knowledge and experience in the I&I therapeutic area is preferred
- Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects.
- Strong methodological skills (study design, data analysis and interpretation) in clinical trials, epidemiology, or health services research is required
- In depth understanding of Pharmacoeconomics and Health-related Quality of Life
- Experience with HTA organizations such as NICE, SMC, PBAC is desirable
- Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
- Excellent oral and written English communication skills required
- Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
- Ability to influence key members of medical and commercial teams constructively and without conflict
- Skilled in functioning within a matrix organization where managing through influence is required
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Ability to travel internationally
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
Additional Offer Details:
- Additional Location Information: New York HQ, Groton CT or Collegeville PA
- Eligible for Employee Referral Bonus - Yes
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.